Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ChiCTR |
Last refreshed on:
|
18 April 2017 |
Main ID: |
ChiCTR-COC-14005302 |
Date of registration:
|
2014-01-05 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Study of the neuropsychology and neuroimaging in First-episode Schizophrenic Patients before and after treatment
|
Scientific title:
|
Study of the neuropsychology and neuroimaging in First-episode Schizophrenic Patients |
Date of first enrolment:
|
2011-11-01 |
Target sample size:
|
Two groups:100; |
Recruitment status: |
Completed |
URL:
|
http://www.chictr.org.cn/showproj.aspx?proj=9603 |
Study type:
|
Cause |
Study design:
|
Case-Control study
|
Phase:
|
Other
|
|
Countries of recruitment
|
China
| | | | | | | |
Contacts
|
Name:
|
Huang Manli
|
Address:
|
No. 79, Qingchun Road, Hangzhou, Zhejiang, China
|
Telephone:
|
+86 13957162975 |
Email:
|
hml1208@sina.com |
Affiliation:
|
|
|
Name:
|
Huang Manli
|
Address:
|
No. 79, Qingchun Road, Hangzhou, Zhejiang, China
|
Telephone:
|
+86 13957162975 |
Email:
|
hml1208@sina.com |
Affiliation:
|
First Affiliated Hospital, College of Medicine, Zh |
| |
Key inclusion & exclusion criteria
|
Inclusion criteria: Study group:
1. patients provided their written and informed consent;
2. patients were between 13-45 years old, males and females;
3. patients with a DSM-IV clinical criteria for Schizophrenic episode;
4. right-handed;
5. patients who are experiencing their first depressive episode and did not use the antipsychotic drug.
Control Group:
1. patients provided their written and informed consent;
2. patients were between 13-45 years old, males and females;
3. right-handed;
4. did not use the antipsychotic drug;
5. healthy.
Exclusion criteria: Patients were excluded if they fell into any of the following categories:
1. had epileptic, Body metal patients and cerebral apoplexy;
2. had severe nerve, heart, liver, kidney, endocrine, blood system diseases or other disturb the estimate of study;
3. had organic mental disorders and mental retardation;
4. had drugs, alcohol or other psychotropic active substance abusers;
5. Pregnant and lactating women.
Age minimum:
18
Age maximum:
45
Gender:
|
Health Condition(s) or Problem(s) studied
|
Schizophrenic
|
Intervention(s)
|
Two groups:neuropsychological test ;
|
Primary Outcome(s)
|
cognitive function;functional connectivity within default state netwo;the brain gray matter density;fractional anisotropy (FA) valus;regional homogeneity (ReHo) valus;PANSS score;
|
Source(s) of Monetary Support
|
The Zhejiang Science and Technology Agency key scientific and technological innovation projects(Y201
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|